Induction of apoptosis in imatinib sensitive and resistant chronic myeloid leukemia cells by efficient disruption of bcr-abl oncogene with zinc finger nucleases

BACKGROUND: The bcr-abl fusion gene is the pathological origin of chronic myeloid leukemia (CML) and plays a critical role in the resistance of imatinib. Thus, bcr-abl disruption-based novel therapeutic strategy may warrant exploration. In our study, we were surprised to find that the characteristic...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Ningshu, Huang, Zhenglan, Gao, Miao, Luo, Zhenhong, Zhou, Fangzhu, Liu, Lin, Xiao, Qing, Wang, Xin, Feng, Wenli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5859405/
https://www.ncbi.nlm.nih.gov/pubmed/29554925
http://dx.doi.org/10.1186/s13046-018-0732-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5859405/
https://www.ncbi.nlm.nih.gov/pubmed/29554925
http://dx.doi.org/10.1186/s13046-018-0732-4

Ejemplares similares